Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satisfaction with Liquid Growth Hormone in SGA Children
NCT00519844Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2005
- Primary completion
- Jan 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Small for gestational age (SGA), sponsored by Novo Nordisk. Primary endpoint: Satisfaction/preference with the method of treatment at 3 months. Started Jul 2005; status: completed.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT00519844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519844.